Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL)

Bone Marrow Transplantation

Volumn 18, Issue 5, 1996, Pages 1017-1019

  Ben Yosef, R ^a   Braverman, I ^a   Saah, D ^a   Nagler, R ^a   Shohat, S ^a   Or, R ^a   Nagler, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Autologous stem cell transplantation; Mucosal melanoma; Non Hodgkin's lymphoma

Indexed keywords

ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TONGUE CANCER;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MELANOMA, AMELANOTIC; MOUTH NEOPLASMS; NEOPLASMS, SECOND PRIMARY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029854622     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tanaka N, Amagasa T, Iwaki H et al. Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 1994; 78: 81-90.
2. Batsakis JG, Regezi JA, Solomon AR, Rice DH. The pathology of head and neck tumors: mucosal melanoma, part 13. Head Neck Surg 1982; 4: 404-418.
3. Kato T, Takematsu H, Tomita Y et al. Malignant melanoma of mucous membranes: a clinicopathologic study of 13 cases in Japanese patients. Arch Dermatol 1987; 123: 216-220.
4. Rapini RP, Golitz LE, Greer RJ et al. Primary malignant melanoma of the oral cavity: a review of 177 cases. Cancer 1985; 55: 1543-1551.
5. Kolb HJ, Duell T, Socie G et al. New malignancies in patients surviving more than 5 years after marrow transplantation. Blood 1995; 86: 1825 (Abstr.).
6. Bhatia B, Ramsay N, Steinbuch M et al. Subsequent malignant neoplasms (SMN) following bone marrow transplantation (BMT). Blood 1995; 86: 1827 (Abstr.).
7. Andre M, Henry-Amar M, Biaise D et al. Incidence of second cancers (SC) and causes of death after autologous stem cell transplantation (ASCT) for Hodgkin's diseases (HD). Blood 1995; 86: 1826 (Abstr.).
8. Sobocinski KA, Rowlings PA, Curtis RE et al. Solid tumors developing after allogeneic bone marrow transplantation. Blood 1995; 86: 1828 (Abstr.).
9. Lishner M, Patterson B, Kandel R et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990; 65: 473-476.
10. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies-shared etiology? Int J Cancer 1995; 62: 519-522.
11. Adami J, Frisch M, Yuen J et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995; 310: 1491-1495.
12. Travis LB, Curtis RE, Glimelius B et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995; 87: 524-530.
13. Lavey RS, Eby NL, Prosnitz LR. Impact of second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 1990; 66: 80-88.
14. Travis LB, Curtis RE, Hankey BF, Fraumeni JF. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84: 1422-1427.
15. Sasieni S. Non-Hodgkin's lymphoma and skin cancer: ultraviolet light is unlikely explanation for association. Br Med J 1995; 311: 749.
16. Gniadecki R. Non-Hodgkin's lymphoma and skin cancer: pathogenesis is multifactorial. Br Med J 1995; 311: 749-750.
17. Vickers M. Non-Hodgkin's lymphoma and skin cancer: association may be iatrogenic. Br Med J 1995; 311: 750.
18. Newtom R. Non-Hodgkin's lymphoma and skin cancer: American data refute ultraviolet hypothesis. Br Med J 1995; 311: 750.
19. Trapp TK, Fu YS, Calcaterra TC. Melanoma of the nasal and paranasal sinus mucosa. Arch Otolarngol Head Neck Surg 1987; 113: 1086-1089.
20. Matias C, Corde J, Soares J. Primary malignant melanoma of the nasal cavity: a clinicopathological study of nine cases. J Surg Oncol 1988; 39: 29-32.
21. Strauss JE, Strauss SI. Oral malignant melanoma: a case report and review of literature. J Oral Maxillofac Surg 1994; 52: 972-976.
22. Umeda M, Shimada K. Primary malignant melanoma of the oral cavity - its histological classification and treatment. Br J Oral and Maxillofac Surg 1994; 32: 39-47.
23. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck 1991; 13: 22-27.
24. Eisen D, Voorhees J. Oral melanomas and other pigmented lesion of the oral cavity. J Am Acad Dermatol 1991; 24: 527-537.
25. Paton LL, Brahim JS, Baker AR. Metastatic malignant melanoma of the oral cavity. Oral Surg Oral Med Oral Pathol 1994; 78: 51-56.
26. Blatchford SJ, Koopmann CF, Coulthard SW. Mucosal melanoma of the head and neck. Laryngoscope 1986; 96: 929-934.
27. Berthelsen A, Andersen AP, Jensen TS, Hansen HS. Melanomas of the mucosa in the oral cavity and the upper respiratory passages. Cancer 1984; 54: 907-912.
28. Ang KK, Byers RM, Peters LJ et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Arch Otolaryngol Head Neck Surg 1990; 116: 169-172.
29. Barth A, Morton D. The role of adjuvant therapy in melanoma management. Cancer 1995; 75 (2 Suppl.): 726-734.
30. Kirkwood J, Strawderman M, Emstoff M. Interferon alfa-2b adjuvant therapy for high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14: 7-14.
31. Creagan E, Dalton R, Ahmann D et al. Randomized surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. J Clin Oncol 1995; 13: 2776-2783.
32. Nagler A, Morecki S, Ackerstein A et al. Experimental and clinical cellular immunotherapy in bone marrow transplantation. In: Morstyn G, Sheridan W (eds). Stem Cell Transplantation, Gene Therapy and Cellular Immunotherapy. Cambridge University Press: New York, 1996, pp 527-549.